Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

Immune checkpoint inhibitors (ICI) are an integral part of bladder cancer therapy, however, the relevance of ICI treatment for mixed and pure squamous cell carcinoma of the bladder remains poorly studied. Ther...

Source: BMC Cancer - March 18, 2020 Category: Cancer & Oncology Authors: Ronja Morsch, Michael Rose, Angela Maurer, Maria Angela Cassataro, Till Braunschweig, Ruth Kn üchel, Thomas-Alexander Vögeli, Thorsten Ecke, Markus Eckstein, Veronika Weyerer, Irene Esposito, Maximilian Ackermann, Günter Niegisch and Nadine T. Gaisa Tags: Research article Source Type: research